刘彩艳, 曲芃芃. IGF-ⅠTGF-β1在卵巢上皮性肿瘤中的表达及与微血管密度的关系[J]. 中国肿瘤临床, 2012, 39(18): 1337-1341. DOI: 10.3969/j.issn.1000-8179.2012.18.002
引用本文: 刘彩艳, 曲芃芃. IGF-ⅠTGF-β1在卵巢上皮性肿瘤中的表达及与微血管密度的关系[J]. 中国肿瘤临床, 2012, 39(18): 1337-1341. DOI: 10.3969/j.issn.1000-8179.2012.18.002
Caiyan LIU, Pengpeng QU. Expression of IGF-I and TGF-β1 in Epithelial Ovarian Cancer and Its Relationship with Tumor Micro-vessel Density[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(18): 1337-1341. DOI: 10.3969/j.issn.1000-8179.2012.18.002
Citation: Caiyan LIU, Pengpeng QU. Expression of IGF-I and TGF-β1 in Epithelial Ovarian Cancer and Its Relationship with Tumor Micro-vessel Density[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(18): 1337-1341. DOI: 10.3969/j.issn.1000-8179.2012.18.002

IGF-ⅠTGF-β1在卵巢上皮性肿瘤中的表达及与微血管密度的关系

Expression of IGF-I and TGF-β1 in Epithelial Ovarian Cancer and Its Relationship with Tumor Micro-vessel Density

  • 摘要:
      目的  检测卵巢上皮性肿瘤中胰岛素样生长因子(IGF-Ⅰ)、转化生长因子(TGF-β1)的表达及肿瘤微血管密度(MVD), 分析其与卵巢癌临床病理特征的关系。
      方法  收集天津市中心妇产科医院2005年12月至2010年5月间诊治的卵巢癌35例, 交界性肿瘤31例, 良性肿瘤30例, 正常卵巢组织20例。通过免疫组织化学法检测IGF-Ⅰ及TGF-β1的表达与MVD。
      结果  上皮性卵巢癌中IGF-Ⅰ及TGF-β1的表达显著高于交界性肿瘤、良性卵巢肿瘤和正常卵巢组织(P < 0.05);1GF-Ⅰ与卵巢癌组织学分级及腹水形成相关(P < 0.05), TGF-β1与腹水形成相关(P < 0.05);MVD与临床分期、组织分级、腹水形成相关(P < 0.05)。IGF-Ⅰ和TGF-β1在各组中的表达存在正相关(r=0.68, P < 0.05);IGF-Ⅰ、TGF-β1的表达与MVD均值存在显著正相关(r=0.45, P=0.01;r=0.39, P=0.02);IGF-Ⅰ、TGF-β1阳性组无瘤生存率及总生存率均有下降的趋势, 但差异无统计学意义(P>0.05)。
      结论  上皮性卵巢癌中, IGF-Ⅰ、TGF-β1的表达与MVD呈正相关。IGF-Ⅰ、TGF-β1和MVD形成在上皮性卵巢癌的发病机理中起着重要作用。

     

    Abstract:
      Objective  To investigate the expression of IGF-I and TGF- & beta; 1 and the formation of tumor micro-vessel density in patients with epithelial ovarian cancer and to analyze the relationship among factors and clinicopathologic features of epithelial ovarian cancer.
      Methods  Immunohistochemical method was used to detect the expression of IGF-I and TGF- & beta; 1 proteins and to observe microvessel density (MVD) formation in 35 cases with epithelial ovarian cancer, 31 cases with borderline tumor, 30 cases with benign tumor, and 20 cases with normal ovarian tissues.
      Results  The expression of IGF-I and TGF- & beta; 1 was significantly higher in epithelial ovarian cancer tissues than in cases with borderline tumor, benign ovarian tumor, and normal ovarian tissues (P < 0.05). Among the patients with epithelial ovarian cancer, the expression of IGF-I was significantly different in various histological grades or ascites (P < 0.05). The expression of TGF- & beta; 1 was related to ascites (P < 0.05), whereas MVD was related to clinical stage, histological grade, and ascites (P < 0.05). The expression level of IGF-I and TGF- & beta; 1 in different tissues was positively correlated (r = 0.68, P < 0.05), similar to the correlation with MVD (r = 0.45, P = 0.01; r =0.39, P = 0.02). The disease-free and overall survival rates in the positive groups of IGF-I and TGF- & beta; 1 exhibited a decrease, whereas no significant differences were observed in both groups (P > 0.05).
      Conclusion  In epithelial ovarian carcinomas, the expression of IGF-I and TGF- & beta; 1 is positively correlated with MVD. IGF-I, TGF- & beta; 1, and MVD formation in epithelial ovarian cancer patients play an important role in pathogenesis.

     

/

返回文章
返回